Follistim Aq
Payments companies reported to CMS as associated with Follistim Aq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Follistim Aq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Follistim Aq
These are the largest totals companies reported as associated with Follistim Aq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Sipe | Glenview, IL | Reproductive Endocrinology | $1,030.26 |
| Vinay Gunnala | Phoenix, AZ | Reproductive Endocrinology | $1,019.42 |
| Tara Denton | Phoenix, AZ | Women'S Health (Nurse Practitioner) | $849.68 |
| Michelle Murphy | Stayton, OR | Family | $834.50 |
| Shane Lipskind | Scottsdale, AZ | Reproductive Endocrinology | $829.96 |
| Shelley Rosander | Phoenix, AZ | Women'S Health (Nurse Practitioner) | $763.58 |
| Anupama Kathiresan | Santa Monica, CA | Reproductive Endocrinology | $740.35 |
| Jane Nani | Glenview, IL | Reproductive Endocrinology | $740.24 |
| Mackenzie Purdy | Creve Coeur, MO | Reproductive Endocrinology | $720.72 |
| Maurice Peress | Boca Raton, FL | Reproductive Endocrinology | $706.70 |
Prescribed Follistim Aq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.